Literature DB >> 25323687

The BRAF-V600E mutation in circulating cell-free DNA is a promising biomarker of high-risk adult Langerhans cell histiocytosis.

Masayuki Kobayashi1, Arinobu Tojo1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25323687     DOI： 10.1182/blood-2014-08-596080

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

Review 1.  Hairy cell leukemia: present and future directions.

Authors:  Robert J Kreitman
Journal:  Leuk Lymphoma       Date:  2019-05-09

2.  Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition.

Authors:  Gil Awada; Teofila Seremet; Karel Fostier; Hendrik Everaert; Bart Neyns
Journal:  Blood Adv       Date:  2018-08-28

Review 3.  Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Authors:  Jean-François Emile; Oussama Abla; Sylvie Fraitag; Annacarin Horne; Julien Haroche; Jean Donadieu; Luis Requena-Caballero; Michael B Jordan; Omar Abdel-Wahab; Carl E Allen; Frédéric Charlotte; Eli L Diamond; R Maarten Egeler; Alain Fischer; Juana Gil Herrera; Jan-Inge Henter; Filip Janku; Miriam Merad; Jennifer Picarsic; Carlos Rodriguez-Galindo; Barret J Rollins; Abdellatif Tazi; Robert Vassallo; Lawrence M Weiss
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

4.  Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH.

Authors:  Alexandra Kolenová; Raphaela Schwentner; Gunhild Jug; Ingrid Simonitsch-Klupp; Christoph Kornauth; Lukáš Plank; Júlia Horáková; Ivana Bodová; Tomáš Sýkora; Lucia Geczová; Wolfgang Holter; Milen Minkov; Caroline Hutter
Journal:  Blood Adv       Date:  2017-02-02

5.  BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.

Authors:  Sébastien Héritier; Jean-François Emile; Mohamed-Aziz Barkaoui; Caroline Thomas; Sylvie Fraitag; Sabah Boudjemaa; Florence Renaud; Anne Moreau; Michel Peuchmaur; Catherine Chassagne-Clément; Frédérique Dijoud; Valérie Rigau; Despina Moshous; Anne Lambilliotte; Françoise Mazingue; Kamila Kebaili; Jean Miron; Eric Jeziorski; Geneviève Plat; Nathalie Aladjidi; Alina Ferster; Hélène Pacquement; Claire Galambrun; Laurence Brugières; Guy Leverger; Ludovic Mansuy; Catherine Paillard; Anne Deville; Corinne Armari-Alla; Anne Lutun; Marion Gillibert-Yvert; Jean-Louis Stephan; Fleur Cohen-Aubart; Julien Haroche; Isabelle Pellier; Frédéric Millot; Brigitte Lescoeur; Virginie Gandemer; Christine Bodemer; Roger Lacave; Zofia Hélias-Rodzewicz; Valérie Taly; Frédéric Geissmann; Jean Donadieu
Journal:  J Clin Oncol       Date:  2016-07-05       Impact factor: 44.544

Review 6.  Update on hairy cell leukemia.

Authors:  Robert J Kreitman; Evgeny Arons
Journal:  Clin Adv Hematol Oncol       Date:  2018-03

7.  Adult Onset of BRAF(V600E)-Mutated Langerhans Cell Histiocytosis with Cutaneous Involvement Successfully Diagnosed by Immunohistochemical Staining.

Authors:  Hisayuki Tono; Taku Fujimura; Aya Kakizaki; Sadanori Furudate; Masaya Ishibashi; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2015-09-12

Review 8.  Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment.

Authors:  Masayuki Kobayashi; Arinobu Tojo
Journal:  Cancer Sci       Date:  2018-10-30       Impact factor: 6.716
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.